Nutralife Biosciences (NTFU) Stock Price, News & Analysis

Company Overview

Nutralife Biosciences, Inc. (OTCMKTS: NTFU) is a Nevada-based development-stage company that operates at the intersection of nutraceuticals and biotechnology. Founded to capitalize on growing demand for science-backed wellness solutions, the company focuses on the discovery, formulation, manufacturing and distribution of natural health products. Nutralife’s core mission is to deliver clinically relevant, plant- and cannabinoid-derived formulations through a GMP-certified facility, leveraging proprietary extraction and encapsulation technologies to maximize bioavailability and therapeutic potential.

The company’s product portfolio spans nutraceutical supplements, botanical extracts and targeted wellness offerings designed to support immune health, joint comfort, cognitive function and sleep quality. Utilizing its in-house research and development laboratory, Nutralife has developed a series of branded formulas that combine traditional herbal actives with modern delivery systems. Distribution channels include direct-to-consumer e-commerce, specialty retail partnerships and international distributors in Canada, Europe and select Asia-Pacific markets. Strategic alliances with contract research organizations and raw material suppliers underpin the company’s scalable manufacturing model and quality control procedures.

Under the leadership of Founder and Chief Executive Officer Eddie Rusyniak, Nutralife Biosciences has pursued a dual strategy of near-term product commercialization and long-term biotech ventures. The management team includes seasoned executives in regulatory affairs, supply chain management and clinical development, positioning the company to navigate complex compliance frameworks and advance its novel pipelines. Looking ahead, Nutralife aims to expand into emerging therapeutic areas—such as cell-based therapies and precision nutraceuticals—and deepen collaborations with academic institutions to drive scientific validation of its core technologies.

Key Stats

• Today's Range: N/A
• 50-Day Range: N/A
• 52-Week Range: N/A
• Volume: N/A
• Average Volume: 45,202 shs
• Market Capitalization: $17.20 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

NTFU Stock Analysis - Frequently Asked Questions

How were Nutralife Biosciences' earnings last quarter?

Nutralife Biosciences Inc (OTCMKTS:NTFU) posted its quarterly earnings results on Tuesday, November, 13th. The company reported ($0.01) earnings per share for the quarter. The company had revenue of $1.06 million for the quarter. Nutralife Biosciences had a negative net margin of 54.51% and a negative trailing twelve-month return on equity of 204.01%.

How do I buy shares of Nutralife Biosciences?

Shares of NTFU stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Nutralife Biosciences own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Nutralife Biosciences investors own include Ford Motor (F), Prudential Financial (PRU), Cineplex (CGX), CNOOC (CEO), Boston Private Financial (BPFH), Bodycote (BOY) and Blue Apron (APRN).

Company Calendar

• Last Earnings: 11/13/2018
• Today: 7/15/2025

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: Dairy Products
• Sub-Industry: Food Products
• Current Symbol: OTCMKTS:NTFU
• CIK: N/A
• Web: www.nutrafuels.com
• Phone: 888-509-8901
• Fax: N/A
• Employees: 10
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$23.62 million
• Net Margins: -54.51%
• Pretax Margin: N/A
• Return on Equity: -204.01%
• Return on Assets: -115.85%

Debt

• Debt-to-Equity Ratio: 0.09
• Current Ratio: 0.83
• Quick Ratio: 0.40

Sales & Book Value

• Annual Sales: $1.79 million
• Price / Sales: 0.00
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $0.01 per share
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 98,658,000
• Free Float: N/A
• Market Cap: $17.20 million
• Optionable: Not Optionable
• Beta: -1.47